Annie Oh

561 total citations
24 papers, 291 citations indexed

About

Annie Oh is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Annie Oh has authored 24 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Annie Oh's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (6 papers) and Hemoglobinopathies and Related Disorders (6 papers). Annie Oh is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (6 papers) and Hemoglobinopathies and Related Disorders (6 papers). Annie Oh collaborates with scholars based in United States and Italy. Annie Oh's co-authors include Damiano Rondelli, Pritesh Patel, Karen Sweiss, Nadim Mahmud, John G. Quigley, Santosh L. Saraf, Irum Khan, Matthew Koshy, David Peace and Michel Gowhari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Bone Marrow Transplantation.

In The Last Decade

Annie Oh

22 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Oh United States 9 170 142 91 60 50 24 291
Kuang‐Yueh Chiang United States 7 63 0.4× 65 0.5× 57 0.6× 28 0.5× 13 0.3× 10 157
Bader Alahmari Saudi Arabia 8 209 1.2× 107 0.8× 35 0.4× 43 0.7× 75 1.5× 38 343
D. Gasperini Italy 9 141 0.8× 165 1.2× 47 0.5× 19 0.3× 81 1.6× 14 343
LA Baxter-Lowe United States 10 368 2.2× 59 0.4× 60 0.7× 24 0.4× 98 2.0× 17 505
Artit Ungkanont Thailand 15 263 1.5× 229 1.6× 65 0.7× 62 1.0× 52 1.0× 28 447
Michael Boo United States 8 179 1.1× 77 0.5× 65 0.7× 28 0.5× 47 0.9× 11 242
Erin E. O’Branski United States 5 356 2.1× 425 3.0× 114 1.3× 51 0.8× 17 0.3× 6 510
Luciana Correa Oliveira de Oliveira Brazil 10 181 1.1× 60 0.4× 14 0.2× 138 2.3× 88 1.8× 31 330
Jared Becksfort United States 6 139 0.8× 30 0.2× 83 0.9× 49 0.8× 78 1.6× 12 368
RA Krance United States 8 280 1.6× 67 0.5× 34 0.4× 81 1.4× 102 2.0× 8 433

Countries citing papers authored by Annie Oh

Since Specialization
Citations

This map shows the geographic impact of Annie Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Oh more than expected).

Fields of papers citing papers by Annie Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Oh. The network helps show where Annie Oh may publish in the future.

Co-authorship network of co-authors of Annie Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Oh. A scholar is included among the top collaborators of Annie Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Oh. Annie Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Pritesh, Vitalyi Senyuk, Karen Sweiss, et al.. (2020). PARP Inhibition Synergizes with Melphalan but Does not Reverse Resistance Completely. Biology of Blood and Marrow Transplantation. 26(7). 1273–1279. 9 indexed citations
2.
Patel, Pritesh, Vitalyi Senyuk, Karen Sweiss, et al.. (2020). Overcoming Melphalan Resistance By Targeting Crucial DNA Repair Pathways in Multiple Myeloma. Biology of Blood and Marrow Transplantation. 26(3). S224–S225. 3 indexed citations
3.
Patel, Pritesh, Vitalyi Senyuk, Natalie Rodríguez, et al.. (2019). Synergistic Cytotoxic Effect of Busulfan and the PARP Inhibitor Veliparib in Myeloproliferative Neoplasms. Biology of Blood and Marrow Transplantation. 25(5). 855–860. 13 indexed citations
4.
Sweiss, Karen, Annie Oh, Gregory S. Calip, Damiano Rondelli, & Pritesh Patel. (2019). Superior Survival in African American Patients Who Underwent Autologous Stem Cell Transplantation for Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(8). e506–e511. 9 indexed citations
5.
Sweiss, Karen, Gregory S. Calip, Annie Oh, Damiano Rondelli, & Pritesh Patel. (2018). Renal dysfunction within 90 days of FluBu4 predicts early and late mortality. Bone Marrow Transplantation. 54(7). 980–986. 5 indexed citations
6.
Saraf, Santosh L., Annie Oh, Pritesh Patel, et al.. (2018). Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease. Biology of Blood and Marrow Transplantation. 24(8). 1759–1765. 43 indexed citations
7.
Saraf, Santosh L., Pritesh Patel, Karen Sweiss, et al.. (2018). Non-Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease. Biology of Blood and Marrow Transplantation. 24(3). S59–S59. 1 indexed citations
8.
Patel, Pritesh, Santosh K. Misra, Natalie Rodríguez, et al.. (2017). Combined Nanoparticle Delivery of PARP and DNA-PK Inhibition for Multiple Myeloma. Blood. 130. 1809–1809. 4 indexed citations
9.
Sweiss, Karen, Jennifer M. Anderson, Annie Oh, et al.. (2017). A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant. Bone Marrow Transplantation. 53(3). 300–306. 10 indexed citations
10.
Oh, Annie, Dolores Mahmud, Nadim Mahmud, et al.. (2017). T Cell–Mediated Rejection of Human CD34+ Cells Is Prevented by Costimulatory Blockade in a Xenograft Model. Biology of Blood and Marrow Transplantation. 23(12). 2048–2056. 4 indexed citations
11.
12.
Oh, Annie, et al.. (2017). Cytopenia of Unknown Cause as a Predictive Marker of Clinical Outcome Post Busulfan Based Allogeneic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 23(3). S291–S291.
13.
Patel, Pritesh, Annie Oh, Vitalyi Senyuk, et al.. (2017). Inhibition of PARP and DNA-PK Lead to Synergistic Cytotoxicity with Melphalan in Multiple Myeloma. Biology of Blood and Marrow Transplantation. 23(3). S269–S269. 1 indexed citations
14.
Sweiss, Karen, John G. Quigley, Annie Oh, et al.. (2017). A novel drug interaction between busulfan and blinatumomab. Journal of Oncology Pharmacy Practice. 25(1). 226–228. 8 indexed citations
15.
16.
17.
Sweiss, Karen, Annie Oh, Damiano Rondelli, & Pritesh Patel. (2016). Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation. SHILAP Revista de lepidopterología. 2016. 1–3. 1 indexed citations
18.
Patel, Pritesh, Vitalyi Senyuk, Elisa Bonetti, et al.. (2016). The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms. Blood. 128(22). 4276–4276. 2 indexed citations
19.
Saraf, Santosh L., Annie Oh, Pritesh Patel, et al.. (2015). Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. Biology of Blood and Marrow Transplantation. 22(3). 441–448. 99 indexed citations
20.
Patel, Pritesh, Bulent Aydogan, Matthew Koshy, et al.. (2014). Combination of Linear Accelerator–Based Intensity-Modulated Total Marrow Irradiation and Myeloablative Fludarabine/Busulfan: A Phase I Study. Biology of Blood and Marrow Transplantation. 20(12). 2034–2041. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kuang‐Yueh Chiang Breakdown of academic impact, for papers by Bader Alahmari Breakdown of academic impact, for papers by D. Gasperini Breakdown of academic impact, for papers by LA Baxter-Lowe Breakdown of academic impact, for papers by Artit Ungkanont Breakdown of academic impact, for papers by Michael Boo Breakdown of academic impact, for papers by Erin E. O’Branski Breakdown of academic impact, for papers by Luciana Correa Oliveira de Oliveira Breakdown of academic impact, for papers by Jared Becksfort Breakdown of academic impact, for papers by RA Krance
Rankless by CCL
2026